Ładuje się......
AT-27 CHALLENGES OF RETROSPECTIVELY DETERMINING THE EQUIVALENCE OF PCV VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED 1p/19q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS
BACKGROUND: For many years, patients with anaplastic oligodendrogliomas (AO) have been treated with radiation and temozolomide followed by adjuvant temozolomide (RT/TMZ). Two randomized studies, RTOG 9402 and EORTC 26951 recently showed significantly improved survival in patients with 1p/19q co-dele...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Oxford University Press
2014
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217805/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.27 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|